Loading product
Loading product
Growth · Research material
Package information
For product inquiries and additional information, contact lonestarpeptideco@gmail.com.
Compliance notice: For laboratory research use only. Not for human or veterinary use.
Product information is intended for laboratory, academic and commercial researchers aged 18 or over.
Material profile
A synthetic hexapeptide secretagogue-receptor ligand containing a 2-methylated D-tryptophan residue, supplied as the acetate salt. Supplied as a lyophilized powder at 2 mg in one vial. A box of 10 is available as an optional package. It is intended for cell-culture and analytical bench work. For laboratory research use only. Not for human or veterinary use.
Catalog record
| Product | Hexarelin Acetate — 2 mg |
|---|---|
| Catalog SKU | HX2 |
| Compound | Hexarelin Acetate |
| Appearance | Lyophilized white powder |
| Fill per vial | 2 mg |
| Storage condition | -20 °C, desiccated, protect from light |
Laboratory handling
Delivered as a sealed lyophilized vial in an insulated cold-pack mailer. Long-term storage is at -20 degrees C in a desiccated, light-protected container. Once opened, the vial should be managed under the receiving laboratory's own SOPs for handling of lyophilized reference materials.
Evidence first
This listing does not currently publish lot-specific analytical results. Request and review the applicable documentation before using the material in laboratory work.
Published literature
Hexarelin is a synthetic growth-hormone-releasing hexapeptide that activates the growth hormone secretagogue receptor (GHS-R1a) as well as the scavenger receptor CD36, which is expressed on cardiomyocytes and microvascular endothelium. In rodent studies, researchers examined hexarelin's association with pituitary growth-hormone release and, separately, with cardiac function markers after experimental ischemia-reperfusion injury and induced myocardial infarction in rats, reporting improved measures of cardiac systolic function and reduced markers of tissue damage in these animal models. Investigators linked the cardiac findings in part to modulation of interleukin-1 signaling downstream of GHS-R1a activation, and separately to CD36-mediated pathways independent of growth-hormone release. Hexarelin has not completed human clinical trials and holds no regulatory approval for any use.
Describes what the cited studies examined in the systems noted above — not a claim about outcomes for people. Not medical advice.
Product support
No downloadable certificate is currently attached to this listing. Email lonestarpeptideco@gmail.com if your laboratory requires lot-specific documentation for review.
Use the package selector to review the single-vial and box-of-10 formats, then use Email to inquire if you want to ask about that product.
The catalog storage condition is -20 °C, desiccated, protect from light. Follow the handling information on this page and your laboratory's written procedures.
No. It is presented only as laboratory research material and is not for human or veterinary use, food, drugs, cosmetics, household use, or self-administration.
Catalog navigation
Other catalog records grouped under the same editorial collection.
Lone Star Peptide Co.
10 mg
Product inquiries
Contact Lone Star Peptide Co. for product information and inquiries.
Email to inquireRequired notice
For laboratory research use only. Not for human or veterinary use, food, drugs, cosmetics, household use, or self-administration. Product information is provided for material identification, handling, and analytical documentation; it is not medical advice or a statement of clinical safety or effectiveness.
